Herbalife's (HLF) Q1 Seen as 'Fairly Ugly' But Valuation Still Attractive: Pivotal Research
Tweet Send to a Friend
Pivotal Research maintained a Buy rating on Herbalife (NYSE: HLF) with a price target of $75. Analyst Timothy S. Ramey ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
